Microservices in Healthcare Market - Global Industry Analysis,Share, Trends, Status and Future Forecast

The benefits of microservice architecture, such as their ability to increase overall efficiency and project delivery speed, are the primary factor driving the market growth. However, concerns regarding security and regulatory compliance and the complexity of architecture are expected to hinder the growth of this market.

According to the new market research report “Microservices in Healthcare Market by Component (Platform, Services (Consulting, Integration, Training, Support, Maintenance)), Delivery (Cloud, Hybrid, Private, On-premise), End User (Health care Provider, Payer, Life Science) – Global Forecast” published by MarketsandMarkets™, is projected to reach USD 343.3 million by 2023 from the estimated USD 103.1 million in 2017, at a CAGR of 21.3%.

The Objectives of this study are as follows:

– To define, describe, and forecast the global microservices in healthcare market by deployment model, component, end user, and region

– To provide detailed information about the major factors influencing market growth (drivers, restraints, opportunities, and industry-specific challenges)

– To strategically analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall market

– To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players

Request Research Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=119908608

Geographically; North America is estimated to command the largest share of the market. The large share of North America in the global microservices in healthcare market can be attributed to the growing focus on improving the overall efficiency of healthcare organizations and greater product and service availability in the region.

The microservices in healthcare market is marked by the presence of several big and small players. Prominent players in this market include AWS (US), CA Technologies (US), Microsoft (US), Salesforce (US), Pivotal Software (US), Infosys (India), IBM (US), NGINX (US), Oracle Corporation (US), and Syntel (US).

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=119908608

Market Segmentation in Detailed:

The platform segment is expected to dominate the microservices in healthcare market in 2018.

Based on component, segmented into platforms and services. The services segment is further segmented into consulting services, integration services, and training, support, and maintenance services. The platforms segment is expected to account for the larger share of the microservices in healthcare market in 2018. This is attributed to the increasing need for cloud microservice architecture for scaling functions at a very granular level for efficient system optimization and organization. Cloud platform microservice architecture also brings a new level of scalability to enterprise applications.

The healthcare providers segment is expected to dominate the market in 2018.

Based on end user, the microservices in healthcare market is segmented into healthcare payers, healthcare providers, life science organizations, and clinical laboratories. The healthcare providers segment is expected to account for the largest share of the overall market in 2018. Government initiatives that help providers gain incentives on the adoption of EHRs and the implementation of integration and connectivity solutions are driving the adoption of microservices architecture solutions among healthcare providers.

Urgent Care Apps Market Size, Opportunities for Revenue Growth, and Future Forecast

The growth of Urgent Care Apps Market is influenced by a number of factors, such as the increasing penetration of smartphones, growing penetration of 3G and 4G networks, rising focus on patient-centric healthcare delivery, and the benefits offered by urgent care apps. However, the wide usage of consumer instant messaging apps, poor internet connectivity in several countries, and the high volume of miscategorized apps on Android and Apple stores are the major factors that are expected to restrain the growth of this market during the forecast period.

According to the new market research report “Urgent Care Apps Market by Type (Emergency Care Triage Apps, In-hospital Communication Apps, Post-hospital Apps (Nurse Communication Apps, Rehab Apps, Medication Management Apps)), Clinical Area (Stroke, Trauma, STEMI) – Global Forecast” published by MarketsandMarkets™, is expected to reach USD 2,515.1 million, at a CAGR of 41.3% during the forecast period.

Objectives of the Study:

• To define, describe, segment, and forecast the global urgent care apps industry by type, clinical area, and region.
• To forecast the size of the urgent care apps market in North America, Europe, Asia Pacific (APAC), Latin America, and the Middle East & Africa.
• To provide detailed information about factors influencing market growth (drivers, restraints, opportunities, and industry-specific challenges).
• To analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall market.

Request Research Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=45792223

Geographically; North America is expected to hold the largest share of the urgent care apps market in 2018, followed by Europe. The growth of the North American apps market is driven by the implementation of regulations in the region regarding the safety of patient data and improving quality of care, increasing penetration of 4G networks, rising need to reduce the escalating healthcare costs, and the rising focus on patient-centric healthcare delivery.

Some of the prominent players in urgent care apps market are Allm (Japan), Pulsara (US), Vocera Communications (US), PatientSafe Solutions (US), Voalte (US), Twiage (US), TigerConnect (US), Imprivata (US), Siilo (Netherlands), Forward Health (UK), Hospify (UK), Argusoft (US), Alayacare (US), Pivot Design Group (Canada), Medisafe (US), Smartpatient (Germany), and Johnson & Johnson (US).

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=45792223

Market Segmentation in Detailed:

The post-hospital apps segment held the largest share of the market in 2018.

On the basis of type, the urgent care apps market is segmented into pre-hospital emergency care & triaging apps, in-hospital communication & collaboration apps, and post-hospital apps. In 2017, the post-hospital apps segment accounted for the largest share of the apps market. With growing concerns about medication noncompliance and medication dosage errors, the adoption of medication management apps is on the rise. Better connectivity and networks have enhanced the outcome of such apps, which is further boosting the adoption of these apps by patients and healthcare professionals.

In 2018, the trauma segment is expected to account for the largest share of the market.

Based on clinical area, the global urgent care apps market is broadly segmented into trauma, stroke, cardiac conditions, and other clinical areas. In 2018, the trauma segment is slated to account for the largest share of the market. The increasing number of road accident across the globe is driving the growth of this segment. As the awareness to address trauma is increasing due to continuous efforts by health organizations, such as WHO, the adoption of apps to manage trauma and casualty among paramedics and emergency centers is also growing.

Ureteroscopy Market 2021 - by Global In-depth Analysis, Regional Outlook, Latest Trend and Forecast

The high incidence of urolithiasis across the globe is a major factor driving the growth of Ureteroscopy Market. The rapidly increasing geriatric population, technological advancements in devices, and improving hospital infrastructures are the other major factors that are expected to support the growth of the flexible ureteroscopy market in the coming years.

According to the new market research report “Flexible and Semi-rigid Ureteroscopy Market by Product (Flexible Ureteroscopes, Semi-rigid Ureteroscopes), Application (Urolithiasis, Urinary Stricture, Kidney Cancer), End User (ASCS, Hospitals), and Region (US, Canada, Asia, Europe) – Global Forecast” published by MarketsandMarkets™, the global semi-rigid ureteroscopy market is expected to reach USD 1,054.1 million, at a CAGR of 5.4%

The Objectives of this Study are as follows:

• To define, describe, and forecast the flexible & semi-rigid ureteroscopy market by product type, application, end user, and region
• To forecast the revenue of the market segments with respect to four main regional segments, namely, North America, Europe, Asia, and the Rest of the World (RoW)
• To identify the micromarkets with respect to drivers, restraints, industry-specific challenges, opportunities, and trends affecting the growth of the market
• To analyze market segments and subsegments with respect to individual growth trends, prospects, and contributions to the overall market

Request Research Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=253934795

Geographically; the flexible and semi-rigid ureteroscopy market is geographically classified into North America, Europe, Asia, and the Rest of the World (RoW). North America is the largest regional market for ureteroscopes majorly due to the high prevalence of kidney stones (and the large number of surgical procedures performed for the same) and the rising healthcare expenditure in this region. Asia is expected to grow at the highest CAGR in the flexible ureteroscopy market during the forecast period. Growth in this region is mainly due to the large patient population.

Some of the major players operating in ureteroscopy market are Olympus (Japan), Stryker (US), Boston Scientific (US), KARL STORZ (Switzerland), Richard Wolf (Germany), ELMED Medical Systems (Turkey), Rocamed (France), Maxer Endoscopy (Germany), ProSurg (US), and Vimex Endoscopy (Poland).

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=253934795

Market Segmentation in Detailed:

Flexible ureteroscopes are expected to account for the largest share of the market in 2018

By type of product, the flexible & semi-rigid ureteroscopes market is further segmented into flexible and semi-rigid ureteroscopes. The flexible ureteroscopes segment is expected to account for the largest share in 2018. The growing incidence of urolithiasis, rising prevalence rate of kidney cancers, and technological advancements in flexible ureteroscopes are the primary factors driving the growth of the ureteroscopy market. The flexible ureteroscopes market is further segmented into fiberoptic and digital ureteroscopes. The digital ureteroscopes segment is expected to account for the larger market share in 2018 owing to the higher efficacy and better image output of these devices.

Hospitals are expected to dominate the flexible and semi-rigid ureteroscopy end-user market in 2018

By end user, the flexible and semi-rigid ureteroscopy market is segmented into hospitals, ambulatory surgical centers, and other end users. The hospitals segment is expected to account for the largest share of the flexible ureteroscopy market. This large share can be attributed to the high number of surgeries performed in hospitals.

Medical Vacuum System Market Research Report 2019-2024 By Key players and Growth Rate

The Factors such technological advancements in vacuum systems, stringent regulatory frameworks mandating the use of vacuum systems, the increasing number of target surgical procedures across major markets, and the rising number of Diagnostic Imaging procedures are driving the growth of the global medical vacuum systems market.

According to the new market research report “Medical Vacuum System Market by Product (Standalone, Centralized, Portable), Technology (Dry Claw, Oil Sealed Rotary Vane, Liquid Ring), Application (Diagnostic, Wound Care, GYN), End user (Pharmaceutical, Diagnostic Labs) – Global Forecast to 2024″ published by MarketsandMarkets™, is estimated to grow at a CAGR of 6.3% to reach USD 1.6 billion.

Recent Developments:

-> In November 2018, Busch LLC (Germany) and Pfeiffer Vacuum Technology AG (Germany) entered into a strategic cooperation agreement in order to enhance segments such as sales & services, R&D developments, and improve the vacuum product line.

-> In October 2018, ConvaTec (UK) received the US FDA 510(k) Clearance for its Avelle Negative Pressure Wound Therapy System.

-> In March 2018, Atlas Copco AB (Sweden) acquired Walker Filtration for USD 38.68 million for enhancing its vacuum business

Request Research Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=150008017

Geographically; North America accounted for the largest share of the medical vacuum systems market in 2018. The dominant position of this region in the medical vacuum systems industry is due to technology advancements; cleanroom mandates, manufacturing guidelines, and surgical protocols; increased number of target medical procedures and trauma cases; a growing number of end users; the rising number of diagnostic imaging procedures; and rising expenditure healthcare infrastructure in the country.

Atlas Copco AB (Sweden), Gardner Denver Holdings (US), Busch Holding GmbH (Germany), Drägerwerk AG & Co. KGaA (Germany), Asahi Kasei ZOLL Medical Corporation (Japan), Olympus Corporation (Japan), ConvaTec (UK), INTEGRA Holdings (US), Allied Healthcare Products Inc. (US), Medela AG (Switzerland), Air Techniques (US), Laerdal Medical (Norway), Precision Medical, Inc. (US), Medicop (Slovenia), and Ohio Medical Corporation (US) are some major players in the global medical vacuum systems market.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=150008017

Market Segmentation in Detailed:

The standalone vacuum systems segment is expected to account for the largest share of the medical vacuum systems market.

On the basis of product type, segmented into standalone vacuum systems, centralized vacuum systems, portable vacuum systems, and accessories. The standalone vacuum systems segment accounted for the largest share of the medical vacuum systems market in 2018. The large share of this segment can be attributed to the large end-user base for compact/standalone products, their technical advantages, and significant adoption among dental clinics and research labs.

The therapeutic applications segment is expected to register the highest growth rate in the vacuum systems market.

On the basis of application, the medical vacuum systems market is segmented into pharma-biotech manufacturing, therapeutic applications, diagnostic applications, and research applications. Therapeutic applications are further segmented into dental, wound care, anesthesiology, and gynecology applications. The therapeutic applications segment is expected to register the highest growth rate due to the rising incidence of dental caries and other periodontal diseases, increasing use of NPWT for diabetic ulcers, and the increasing number of target medical procedures across major markets.

Medical Device Security Market - Growth by Top Key Players, Application and Forecast Analysis

The Factors such as increasing instances of healthcare cyber-attacks and threats, growing geriatric population and the subsequent growth in chronic disease management, government regulations and need for compliance, growing demand for connected medical devices, and increasing adoption of BYOD and IoT are driving the growth of the device security market.

According to the new market research report “Medical Device Security Market by Solution (Encryption, Antivirus, Identity & Acess Management), Services (Professional, Managed), Type (Network Security, Endpoint Security), Device Type, End User (Healthcare Provider) – Global Forecast” published by MarketsandMarkets™, is projected to reach USD 6.59 Billion by 2023, at a CAGR of 8.6% during the forecast period.

Objectives of the study:

• To define, describe, and forecast the global medical device security market by component (solution and services), type, device type, end user, and region
• To provide detailed information about factors affecting the growth of the market (drivers, restraints, opportunities, and challenges)
• To analyze micro-markets with respect to individual growth trends, prospects, and contributions to the overall market
• To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
• To profile key players in this market and comprehensively analyze their market shares and core competencies

Request Research Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=70612561

Geographically; the Medical Device Security Market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. In 2018, North America is expected to dominate the market followed by Europe. The market in North America is primarily driven by increasing instances of cyberattacks on medical devices, growing adoption of connected medical devices, increasing awareness among healthcare professionals regarding cybersecurity, and government initiatives to implement security solutions are driving the market in region.

The prominent players in the global medical device security market include Cisco Systems (US), IBM Inc. (US), GE Healthcare (US), Symantec Inc.(US), CA Technologies (US), Philips (Netherlands), DXC Technology (US), CloudPassage (US), FireEye (US), Check Point Software Technologies (Israel), Sophos (UK), Imperva (US), Fortinet (US), Palo Alto Networks (US), ClearDATA (US), and Zscaler (US).

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=70612561

Market Segmentation in Detailed:

The endpoint security segment is estimated to have the largest share of the market in 2018.

Based on type, the medical device security market is broadly divided into application security, endpoint security, network security, cloud security, and other security types (email, web, and database security). The endpoint security segment is expected to dominate the market in 2018. The large share of this segment is attributed due to the increasing number of connected medical devices, networks are becoming more vulnerable to new and sophisticated threats such as zero-day malware, trojans, and APTs. Additionally, the trend of bring your own device (BYOD), social media usage, and cloud synchronizing tools are also driving the demand for endpoint security.

The wearable and external medical devices are expected to witness the highest growth during the forecast period.

Based on device type, the medical device security market is segmented into hospital medical devices, internally embedded medical devices, and wearable and external medical devices. The wearable and external medical devices segment is expected to register the highest CAGR during the forecast period. This growth is attributed to the demand for home healthcare owing to the high and rising prevalence of chronic diseases and the growing need to reduce healthcare costs. These factors are increasing the demand and uptake of wearable and external medical devices for remote patient monitoring.

Bronchoscopy Market - Segmentation, Major Players & Geographical Analysis

The growth of Bronchoscopy Market is primarily driven by the growing hospital investments in bronchoscopy facilities, rising demand for bronchoscopy owing to the rising prevalence of respiratory diseases, the growing demand for minimally invasive surgery, and technological advancements in bronchoscopy. However, the dearth of trained physicians and pulmonologists is the major challenge for the growth of this Bronchoscopy Equipment Market.

According to the new market research report “Bronchoscopy Market by Product Bronchoscopes (Flexible, Rigid, EBUS), Imaging Systems (Monitor, Camera), Accessories, Working Channel Diameter (2.8, 2.2, 3.0), Usability (Reusable, Disposable), & End Users (Hospital, ACSs/Clinic) – Global Forecast to 2024” published by MarketsandMarkets™, the Bronchoscopy Equipment Market is projected to reach USD 2.6 billion by 2024 from an estimated USD 2.0 billion in 2019 at a CAGR of 5.9% during the forecast period.

Request Research Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=40057877

Geographically; North America dominated the bronchoscopy equipment market in 2018. The large share of North America in the global bronchoscopy market is attributed to the increase in the incidence and prevalence of chronic respiratory diseases, favorable reimbursement scenario in the US, and rising incidence of lung cancer in Canada.

The Asia Pacific market, on the other hand, is projected to register the highest growth during the forecast period. Factors such as the increasing number of hospitals, developing healthcare infrastructure, increasing healthcare expenditure, rising geriatric population, and the presence of a large patient population are driving the growth of the Bronchoscopes market in the Asia Pacific.

The key players in the global bronchoscopy market are Olympus Corporation (Japan), KARL STORZ (Germany), and FUJIFILM Holdings Corporation (Japan). Other prominent players in the market include Ambu A/S (Denmark), Boston Scientific (US), Ethicon (US), Medtronic (Ireland), HOYA Corporation (Japan), Richard Wolf GmbH (Germany), Cook Medical (US), CONMED Corporation (US), Roper Technologies (US), Teleflex Incorporated (US)

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=40057877

Market Segmentation in Detailed:

The bronchoscopes segment accounted for the largest share of the market in 2018.

Based on product, segmented into bronchoscopes, imaging systems, accessories, and other bronchoscopy equipment. The bronchoscopes segment accounted for the largest share of the bronchoscopy market in 2018. The large share of this segment can be attributed to the high cost of bronchoscopes compared to the imaging systems and accessories, increasing prevalence of lung cancer, and technological advancements.

Hospitals accounted for the largest market share in 2018.

Based on end user, segmented into hospitals and ambulatory surgery centers/clinics. The hospitals segment accounted for the largest share of the bronchoscopy market in 2018. The large share of this segment can be attributed to the high patient preference for hospital treatment, availability of skilled healthcare professionals, and favorable reimbursement scenario.

Medical Radiation Detection Market Professional Survey Report 2019

The growth in Medical Radiation Detection, Monitoring and Safety Market is attributed to the increasing use of nuclear medicine and radiation therapy for diagnosis and treatment, growing number of diagnostic imaging centers, rising prevalence of cancer, increasing safety awareness among people working in radiation-prone environments, and the growing number of people covered by insurance.

According to the new market research report “Medical Radiation Detection, Monitoring and Safety Market by Detector (Gas-Filled Detectors, Scintillators, Solid-State), Product (Personal Dosimeters, Passive Dosimeters), Safety (Full Body Protection), End User (Hospitals) – Global Forecast to 2025” published by MarketsandMarkets™, the global medical radiation monitoring and safety market size is projected to reach USD 1,207 million by 2025 from USD 949 million in 2020, at a CAGR of 4.9% during the forecast period

GROWTH DRIVER: Increasing use of nuclear medicine and radiation therapy for diagnosis and treatment;

According to the World Nuclear Association, more than 40 million nuclear medicine procedures are performed every year, and the demand for radioisotopes is increased at a rate of 5% annually (data as of May 2020). Radioisotopes are used by nearly 10,000 hospitals across the globe. In the US alone, annually, more than 20 million nuclear medicine procedures are performed. According to the World Nuclear Association, North America dominates the diagnostic radioisotopes market and accounts for ~50% of the market share (the US is the largest contributor to the North American diagnostic radioisotopes market), followed by Europe which accounts for a share of ~20%.

Request Research Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=1200

Geographically; the medical radiation detection, monitoring and safety market is segmented into four major regional segments, namely, North America, Europe, Asia Pacific, and the Rest of the World. In 2019, North America accounted for the largest share of the medical radiation detection market. The large share of North America can be attributed to factors such as the increasing awareness about radiation safety, growing number of radiodiagnostic procedures performed, and ongoing research aimed at the development of new and advanced radiation detection, monitoring, and safety products are driving the growth of the North American medical radiation detection, monitoring, and safety market.

The major players in the medical radiation detection, monitoring and safetymarket are Fortive Corporation (US), Mirion Technologies (US), IBA Worldwide (Belgium), Thermo Fisher Scientific (US), and Sun Nuclear Corporation (US).

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=1200

Market Segmentation in Detailed:

Gas-filled detectors accounted for the larger share of the medical radiation detection and monitoring market in 2019

Based on the detector type, the medical radiation detection and monitoring market is segmented into gas-filled detectors, solid-state detectors, and scintillators. In 2019, the gas-filled detectors segment accounted for the largest market share of medical radiation detection and monitoring market . The large share of this segment can be attributed to the favorable performance-to-cost ratio of gas-filled detectors coupled with their wide application in the medical imaging field.

Hospitals are the largest end-users of the medical radiation detection, monitoring and safety market

Based on end-users, the medical radiation detection safety market is segmented into hospitals and non-hospitals. The hospital segment accounted for the largest market share in 2019 due to the increasing number of hospitals across the globe is the major factor driving the growth of this end-user segment

Allergy Diagnostics Market Size, Share, Outlook, Industry Analysis Report

The Research Report on “Allergy Diagnostics Market by Products (Assay Kits, Immunoassay & Elisa Analyzers, Luminometers, Services), Allergens (Food, Inhaled, Drug), Tests (In Vivo, In Vitro), End Users (Hospital, Diagnostic Laboratory) – Global Forecast” published by MarketsandMarkets™, the market witnessed healthy growth during the last decade and is expected to grow at a CAGR of 10.5%, and projected to reach USD 5.74 Billion.

The allergy diagnosis is an important introductory step for effective allergy treatment. Current allergy tests are more convenient and accurate compared to the tests that were available before. With the help of a detailed medical history, allergy tests can identify specific triggers for an individual’s allergic reactions. This process is also required in drug development and the production process of allergy treatments.

The major factors driving the growth of this market are the high incidence and large economic burden of allergic diseases, rising environmental pollution, increasing healthcare expenditure, and growing access to medical insurance in the US. On the other hand, lack of awareness of allergic diseases in some countries is restraining the growth of this market.

Request Research Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=232871701

Opportunity: Growing adoption of automation for quicker turnaround times;

Turnaround time (TAT) is an important factor in laboratory services and is often used as a key indicator of laboratory performance. Fully automated immunoassay systems are popular as they improve the TAT of laboratories and reduce labor costs. Semi-automated instruments are also preferred as they are less expensive; however, these systems increase the TAT. To meet the requirement of increased on-board testing capacity, advanced allergy diagnostic tests have been introduced in the market. Also, the market is witnessing greater adoption of automation for quicker TAT.

Automation in laboratories helps increase the efficiency of laboratory workflows, thus maintaining high throughputs. The main objective of automation in laboratories is to minimize nonvalue-adding steps, such as tube sorting, centrifugation, loading of analyzers, and preparing and sorting of materials required for testing. Some large laboratory chains are now shifting toward complete or total laboratory automation (TLA). However, these laboratories require major financial commitment.

The inhaled allergens segment is expected to grow at the highest CAGR during the forecast period

Based on the allergen, the allergy diagnostics market is segmented into inhaled allergens, food allergens, drug allergens, and other allergens. The inhaled allergens segment is expected to witness the highest growth during the forecast period owing to the increasing environmental pollution levels across the globe.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=232871701

Geographical View in-detailed:

The allergy diagnostics market is segmented into four major regions, namely, North America, Europe, Asia, and the Rest of the World. North America accounted for the largest share of this market owing to the high healthcare expenditure and the strong presence of key market players in the region. These factors, coupled with the rising prevalence of different types of allergies, have resulted in the wide availability and adoption of various allergy diagnostic products and services in the US and Canada.

Global Key Leaders:

The key players operating in the allergy diagnostics market include Thermo Fisher Scientific Inc. (US), Siemens AG (Germany), Danaher Corporation (US), Omega Diagnostics Group PLC (UK), Hitachi Chemical Co., Ltd. (Japan), bioMérieux SA (France), Stallergenes Greer (UK), HOB Biotech Group Suzhou Co., Ltd. (China), HYCOR Biomedical (US), Lincoln Diagnostics, Inc. (US), EUROIMMUN AG (Germany), INDOOR Biotechnologies, Inc. (US), DR. FOOKE – Achterrath Laboratorien GmbH (Germany), R-Biopharm AG (Germany), GA Generic Assays GmbH (Germany), Tecan Trading AG (Switzerland), DST Diagnostische Systeme & Technologien GmbH (Germany), ROXALL Medical GmbH (Germany), ALK-Abelló A/S (Denmark), Astra Biotech GmbH (Germany), HAL Allergy Group (Netherlands), Theradiag (France), and Demeditec Diagnostics GmbH (Germany).

Kidney Function Test Market by top Key Players, Growth Revenue, share, Future Forecast

The Growth in Kidney/Renal Function Test Market can primarily be attributed to factors such as the rising prevalence of kidney disease, growing prevalence of diabetes and hypertension, and the rise in alcohol consumption are driving the growth of the market.

Expected Revenue Surge: The Global Kidney Function Test Market expected to reach USD 790.1 Million, growing at a CAGR of 6.1% during the forecast period.

Objectives of the Study:

• To define, describe, segment, and forecast the global kidney function test market by product, type, end user, and region
• To provide detailed information regarding the major factors influencing the growth of the market (drivers, restraints, opportunities, and challenges)
• To strategically analyze micromarkets with respect to the individual growth trends, prospects, and contributions to the overall market
• To analyze opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
• To profile the key players and comprehensively analyze their product portfolios, market shares, and core competencies in the global kidney/ renal function test market

Request Research Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=40239083

Market Segmentation in Detailed:

By product; the Kidney Function Test Market is categorized into dipsticks, reagents, and disposables. Dipsticks are expected to account for the largest share of the market in 2017, they are also expected to grow at the highest CAGR during the forecast period. The large share and high growth rate of this segment can be attributed to factors such as the cost-effectiveness of dipstick testing and its widespread applications across specializations.

Based on Type, the Renal Function Test Market is segmented into urine and blood tests. Urine tests are further categorized into urine protein, creatinine clearance, and microalbumin. Similarly, blood tests are categorized into serum creatinine, glomerular filtration rate (GFR), and blood urea nitrogen (BUN).

In 2017, the urine tests segment is expected to account for the largest share of the market. This segment is also expected to grow at the highest CAGR during the forecast period. Factors contributing to the large share and high growth rate of this segment include increasing usage of urine dipsticks analysis, the ease in sample collection technique compared to blood samples, and this method also has a very limited risk of infection.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=40239083

Geographically; North America is expected to account for the largest share of the global kidney/renal function test market. The large share of the North American market is attributed to the increasing incidence of chronic diseases, rising prevalence of hypertension, growing incidence of diabetes in the US, and increasing initiatives by the Canadian government for the treatment of kidney diseases.

The prominent players in the global kidney/renal function test market are Abbott (US), Siemens (Germany), Sysmex (Japan), Beckman Coulter (US), Roche (Switzerland), ACON Laboratories, Inc. (US), URIT Medical (China), Nova Biomedical (US), ARKRAY (Japan), OPTI Medical (US), 77 Elektronika (Hungary), and Randox Laboratories (UK).